Mrs Casey A Cantelli, LMFT | |
985 Washington St, Braintree, MA 02184-5434 | |
(857) 267-1143 | |
Not Available |
Full Name | Mrs Casey A Cantelli |
---|---|
Gender | Female |
Speciality | Marriage & Family Therapist |
Location | 985 Washington St, Braintree, Massachusetts |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1780011833 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
106H00000X | Marriage & Family Therapist | 1385 (Massachusetts) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Casey A Cantelli, LMFT 985 Washington St, Braintree, MA 02184-5434 Ph: (857) 267-1143 | Mrs Casey A Cantelli, LMFT 985 Washington St, Braintree, MA 02184-5434 Ph: (857) 267-1143 |
News Archive
Diabetes now affects nearly 24 million people in the United States, an increase of more than 3 million in approximately two years, according to new 2007 prevalence data estimates released today by the Centers for Disease Control and Prevention (CDC). This means that nearly 8 percent of the U.S. population has diabetes.
After a stroke, patients typically have trouble walking and few are able to regain the gait they had before suffering a stroke. Researchers funded by the National Institute of Biomedical Imaging and Bioengineering have developed a computational walking model that could help guide patients to their best possible recovery after a stroke.
When Jorge Newbery finally got through to his 95-year-old mother, Jennifer, on a video call April 18, she could barely talk or move and her eyes couldn't focus.
Watson Pharmaceuticals, Inc. today announced it has initiated its Phase 3 trial to evaluate the efficacy and safety of Esmya (ulipristal acetate) in women with anemia associated with uterine leiomyomas, a medical condition often referred to as uterine fibroids (myomas). Leiomyomata are benign solid tumors that often lead to excessive menstrual bleeding, anemia and pain, which ultimately may require surgical intervention.
MannKind Corporation has announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) requesting approval of Afresa (insulin monomer human [rDNA origin]) Inhalation Powder and the Afresa Inhaler for the treatment of adults with type 1 or type 2 diabetes mellitus for the control of hyperglycemia.
› Verified 5 days ago